Trials in Long Beach, California
Here are the top 10 medical studies for lung cancer in Long Beach, California
Popular Filters
Phase 3 Trials
Checkpoint Inhibitor
Pembrolizumab/Vibostolimab + Chemoradiotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Long Beach, California
This trial tests a combination of two drugs, pembrolizumab and vibostolimab, along with standard chemotherapy and radiation in patients with advanced lung cancer that cannot be surgically removed. The goal is to see if this combination can better control the disease and improve survival compared to another drug, durvalumab. These drugs help the immune system attack cancer cells more effectively.
Small Molecule Kinase Inhibitor
Savolitinib + Osimertinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
La Jolla, California
This trial is testing a new drug combination for lung cancer patients whose previous treatment didn't work. The new drugs aim to block two pathways that help cancer grow, potentially making the treatment more effective.
PARP Inhibitor
Ceralasertib + Durvalumab for Lung Cancer
Recruiting3 awardsPhase 3
Los Alamitos, California
This trial tests a new combination of drugs (ceralasertib and durvalumab) against a standard treatment (docetaxel) in patients with advanced lung cancer who didn't respond to previous treatments. The new combination aims to weaken cancer cells and boost the immune system, while the standard treatment directly kills the cancer cells.
Small Molecule Kinase Inhibitor
Lazertinib + Amivantamab for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Long Beach, California
This trial is testing a new, easier to use formulation of amivantamab, which has the potential to reduce administration time and improve the patient and physician experience.
Trials With No Placebo
CAR T-cell Therapy
NK Cells +/− Atezolizumab for Lung Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial tests a new treatment using modified immune cells from umbilical cord blood to fight advanced lung cancer that didn't respond to previous treatments. Some patients will also receive a drug that boosts the immune system's ability to attack cancer. The goal is to find the best dose and see if the treatment is safe and effective.
Checkpoint Inhibitor
Pembrolizumab/Vibostolimab + Chemoradiotherapy for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Long Beach, California
This trial tests a combination of two drugs, pembrolizumab and vibostolimab, along with standard chemotherapy and radiation in patients with advanced lung cancer that cannot be surgically removed. The goal is to see if this combination can better control the disease and improve survival compared to another drug, durvalumab. These drugs help the immune system attack cancer cells more effectively.
CAR T-cell Therapy
LYL797 for Breast and Lung Cancer
Recruiting1 awardPhase 1
Santa Monica, California
This trial is testing a new treatment called LYL797, which uses modified immune cells to target and kill hard-to-treat breast and lung cancer cells. The study aims to find a safe dose and see how well it works in patients whose cancers have not responded to other treatments.
Small Molecule Kinase Inhibitor
Savolitinib + Osimertinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
La Jolla, California
This trial is testing a new drug combination for lung cancer patients whose previous treatment didn't work. The new drugs aim to block two pathways that help cancer grow, potentially making the treatment more effective.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.